Advertisement

Topics

Portola Pharmaceutical Inc. Company Profile

05:26 EDT 25th September 2018 | BioPortfolio

Portola Pharmaceutical Inc. is a private biopahrmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular disease

Location

270 East Grand Avenue, Suite 22
South San Fransisco
California
94080
United States of America

Contact

Phone: 650-246-7376
Email: careers@PORTOLA.COM


News Articles [282 Associated News Articles listed on BioPortfolio]

Portola Pharma CEO Bill Lis Plans to Retire from Company, Board

Portola Pharmaceuticals (NASDAQ: PTLA) CEO Bill Lis is retiring from the South San Francisco, CA, drug developer. Lis will also retire from Portola’s board of directors. The company said Lis will re...

Portola Pharma Picks Scott Garland to Succeed Bill Lis as CEO

Scott Garland will become president and CEO of Portola Pharmaceuticals (NASDAQ: PTLA) effective Oct. 8. Garland will also join the South San Francisco, CA, company’s board of directors. Garland is c...

Quotidian Technical Highlights on Selected Biotech Stocks -- Portola Pharma, Protalix ...

www.wallstequities.com/registration Portola Pharmaceuticals On Monday, shares in South San Francisco, Californiaheadquartered Portola Pharmaceuticals Inc. recorded a trading volume of 1.48 million...

Six New Drugs Get EMA Nod, Radius and Portola To Fight Rejections

Two products that the European Medicines Agency this week said should not be authorized for sale in the EU are...    

Portola's anticoagulation reversal treatment gets FDA nod

Portola Pharmaceuticals' Andexxa was approved by the FDA as an antidote for patients treated with rivaroxaban and apixaban wh -More- 

FDA approves Andexxa in major boost to Portola

Shares in Portola jumped on the news, reflecting investor relief the FDA did not require additional clinical study before okaying the reversal agent.

FDA Gives Portola Pharma’s Andexxa a Thumbs-up

The U.S. Food and Drug Administration (FDA) approved Portola Pharmaceuticals’ Andexxa, an antidote for blood thinners rivaroxaban and apixaban.

Portola inches closer to large-scale Andexxa production

Roll-out of the anticoagulant antidote has so far been limited to only a few dozen centers as Portola awaits approval of a second-gen production process.

PubMed Articles [477 Associated PubMed Articles listed on BioPortfolio]

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates.

Within (European) healthcare systems, the predominant goal for pharmaceutical expenditure is cost containment. This is due to a general belief among healthcare policy makers that pharmaceutical expend...

Applications of various analytical techniques in quality control of pharmaceutical excipients.

Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...

The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis.

The non-medical use (NMU) of pharmaceutical drugs is an increasing public health concern. This systematic review consolidates current knowledge about how pharmaceutical drugs are obtained for NMU and ...

Applications of proteomics in pharmaceutical research and development.

The significance of proteomics in the pharmaceutical industry has increased since overcoming initial difficulties. This review discusses recent proteomics publications from pharmaceutical companies to...

Solid-state insight into the action of a pharmaceutical solvate: structural, thermal and dissolution analysis of indinavir sulfate ethanolate.

The crystal structure of indinavir sulfate, a pharmaceutical administered as an ethanol solvate, is presented, revealing a unique channel/ionic solvate structure to be characteristic of the compound. ...

Clinical Trials [318 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Improving Compliance Among Elderly Polypharmacy Users Through Community Pharmacy Based Pharmaceutical Care Program

The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...

Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older

The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...

Individualized Pharmaceutical-care for Inpatients With Cancer Pain

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant inpatients

Companies [1040 Associated Companies listed on BioPortfolio]

Portola Pharmaceutical Inc.

Portola Pharmaceutical Inc. is a private biopahrmaceutical company dedicated to the discovery, development and commercialization of novel therapeutics for acute and chronic cardiovascular and vascular...

Merck and Portola Pharmaceuticals

Portola Pharmaceuticals discovers and develops innovative therapeutics based on targets with established proof of concept that are designed to provide significant advances over cu...

Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals develops innovative therapeutics based on targets with established proofs of concept that are designed to provide significant advances over current treatments for cardiovascula...

Biogen Idec and Portola Pharmaceuticals

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in ...

Pharmaceutical Online

Pharmaceutical Online, the pharmaceutical manufacturing industry’s leading Web site. Our online community serves the product-sourcing and information-seeking needs of pharmaceutical professionals wo...

More Information about "Portola Pharmaceutical Inc." on BioPortfolio

We have published hundreds of Portola Pharmaceutical Inc. news stories on BioPortfolio along with dozens of Portola Pharmaceutical Inc. Clinical Trials and PubMed Articles about Portola Pharmaceutical Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Portola Pharmaceutical Inc. Companies in our database. You can also find out about relevant Portola Pharmaceutical Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record